Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 11:30 a.m. (Eastern Time) on Friday, October 18th. Kathy Wengel, Executive Vice President & Chief Global Supply Chain Officer; Dr. Susan Nicholson, Vice President of Women’s Health in our Medical Safety Organization; Lynne Szczepaniak, Vice President Regulatory Affairs, Consumer; and Chris DelOrefice, Vice President Investor Relations will be on the call. The call will last approximately 15 minutes.
- Investors and other interested parties can access the conference call by dialing 877-869-3847 (toll free)/201-689-8261 (toll) or through this link: Conference Call
- A replay of the conference call will be available approximately two hours after the conference call concludes until approximately 12:00 a.m. on October 26, 2019. The replay dial-in number for U.S. participants is 877-660-6853. For participants outside the U.S., the replay dial-in number is 201-612-7415. The replay conference ID number for all callers is 13695940.
About Johnson & Johnson
At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the world’s largest and most broadly-based health care company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity.